Skip to search formSkip to main content

Pentaxim

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pentavac

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers 15-18 Months of Age in Mexico: A Randomized…
BACKGROUND The live, attenuated, tetravalent dengue vaccine (CYD-TDV) is licensed in a number of dengue endemic countries for… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2016
2016
The Immunogenicity and Safety of a Combined DTaP-IPV//Hib Vaccine Compared with Individual DTaP-IPV and Hib (PRP~T) Vaccines: a Randomized Clinical Trial in South Korean Infants
Recommended infant vaccination in Korea includes DTaP-IPV and Hib vaccines administered as separate injections. In this… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2012
2012
Immunogenicity and safety of a DTaP-IPV//PRP∼T vaccine (Pentaxim) booster dose during the second year of life in Indian children primed with the same vaccine
ObjectiveTo evaluate the immunogenicity and safety of a pentavalent (diphtheria, tetanus, acellular pertussis, inactivated… Expand
  • table I
  • table II
  • table III
Is this relevant?
2011
2011
Immunogenicity and safety of an investigational hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae B conjugate combined vaccine in healthy 2…
BACKGROUND AND AIMS Assessment of a new, fully liquid, investigational hexavalent DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim, Sanofi… Expand
Is this relevant?
2011
2011
Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of…
OBJECTIVE To assess the immunogenicity and safety data for a pentavalent combination vaccine containing acellular pertussis… Expand
  • figure 1
  • table II
  • table I
  • figure 2
  • table III
Is this relevant?
2011
2011
One-year post-primary antibody persistence and booster immune response to a DTaP-IPV//PRP~T vaccine (Pentaxim) given at 18 - 19 months of age in South African children primed at 6, 10 and 14 weeks of…
OBJECTIVE To assess the immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated… Expand
  • table I
  • table II
  • figure 1
  • table III
Is this relevant?
2010
2010
Evaluation of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) at 2, 4, and 6 months of age plus hepatitis B vaccine at birth, 2, and 6…
The objective of this study was to evaluate the immunogenicity and safety of a pentavalent vaccine (Pentaxim) containing… Expand
Is this relevant?
2010
2010
A case of acute disseminated encephalomyelitis mimicking leukodystrophy.
Acute disseminated encephalomyelitis (ADEM) is a monophasic, immune-mediated demyelinating disorder that can follow immunizations… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2009
2009
Immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type B conjugate combination vaccine (Pentaxim) with hepatitis B…
OBJECTIVE To obtain immunogenicity and safety data for a pentavalent combination vaccine (diphtheria, tetanus, acellular… Expand
Is this relevant?
2009
2009
Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
This study assessed the booster immune response to a pentavalent combination vaccine containing diphtheria, tetanus, acellular… Expand
Is this relevant?